Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
FLRY3.SA
Strong BuyFleury S.A. · Healthcare · Brazil · $2.0B · Avg Vol: $13M/d
99
StockRankGet insider-trade alerts
Q
65
V
80
M
77
P/E (TTM)
16.1x
ROE
12.6%
D/E
1.0x
Dividend %
6.5%
COMPANY DESCRIPTION
Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.5B | 6.5B | 7.7B | 8.3B | 22.9% | 8.9B | 9.2B | 9.8B | 8.6% |
| EPS (BRL) | 0.95 | 0.87 | 1.13 | 1.12 | 5.5% | 1.17 | 1.32 | 1.51 | 16.2% |
| Shares | 384.7M | 545.0M | 544.3M | 545.0M | +41.7% | 543.6M | — | — | — |
| Debt | 3.7B | 4.2B | 5.4B | 5.3B | 12.7% | 5.5B | — | — | — |
| Equity | 2.7B | 5.1B | 5.3B | 5.0B | 23.1% | — | — | — | — |
| Op CF | 987.1M | 1.4B | 1.9B | 2.1B | 29.3% | 2.3B | — | — | — |
| Inv CF | -1.4B | -17.1M | -2.1B | -516.1M | — | — | — | — | — |
| Fin CF | 380.9M | -1.4B | 126.0M | -1.6B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+16.5%
SMA 50SMA 200
Close
$3.63
RSI (14)
61.6
52W High
$3.71
From 52W High
1.0%
SCORE BREAKDOWN
Quality
65
ROIC
13.8%82.4
ROE
12.6%78.0
GP/Assets
18.0%42.8
Op. Margin
17.1%78.8
FCF/Assets
11.9%89.7
Piotroski
497.6
Int. Cover
2.1x44.2
D/E Ratio
0.98x15.0
Current Ratio
1.86x35.6
Value
80
P/E (TTM)
16.1x69.0
EV/EBITDA
7.0x84.0
P/FCF
6.4x90.4
P/B
2.0x60.2
P/S
1.2x80.9
Div Yield
6.5%95.4
Momentum
77
52W High %
98%97.0
RS 6M
22%81.1
SMA 50/200
1.06x71.7
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+30%43.5
Q Growth
46%72.7
FUNDAMENTALS
Market Cap
$2.0B
P/E (Forward)
12.3x
Gross Margin
27.1%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of FLRY3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| FLRY3.SA | Fleury S.A.(you) | $2.0B | 99 | Strong Buy |
| DASA3.SA | Diagnósticos da América S.A. | $636M | 59 | Hold |
| HYPE3.SA | Hypera S.A. | $3.0B | 97 | Strong Buy |
| SAUD3.SA | Bradsaúde S.A. | $7.9B | 97 | Strong Buy |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 97 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 94 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 88 | Strong Buy |
| PFRM3.SA | Profarma Distribuidora de Produtos Farmacêuticos S.A. | $179M | 98 | Strong Buy |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $490M | 75 | Buy |
Peer medians: ROE 10.5% · P/E 12.4x · Gross margin 31.0%